SNCA and neuroblastoma: Indeed, treatment with a GCase inhibitor Conduritol B epoxide (CBE) caused a large increase in the levels of α-synuclein, without increasing α-synuclein mRNA, in human neuroblastoma SH-SY5Y cells and in mice (161).